These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 688277)

  • 21. Influence of the stage of advancement of leukemia L1210 in mice on the optimal schedule of treatment of cytosine arabinoside (NSC-63878).
    Kline I; Woodman RJ; Gang M; Sirica A; Venditti JM; Goldin A
    Cancer Chemother Rep; 1972 Jun; 56(3):327-34. PubMed ID: 19051491
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of antileukemic agents in advanced leukemia L1210 in mice. IX.
    Kline I; Gang M; Tyrer DD; Venditti JM; Artis EW; Goldin A
    Cancer Chemother Rep 2; 1971 Apr; 2(1):65-133. PubMed ID: 5565539
    [No Abstract]   [Full Text] [Related]  

  • 23. Circadian dependence of host and tumor responses to cyclophosphamide in mice.
    Cardoso SS; Avery T; Venditti JM; Goldin A
    Eur J Cancer (1965); 1978 Sep; 14(9):949-54. PubMed ID: 710487
    [No Abstract]   [Full Text] [Related]  

  • 24. Enhancement of the cancer chemotherapeutic effect of cytosine arabinoside entrapped in liposomes on mouse leukemia L-1210.
    Kobayashi T; Tsukagoshi S; Sakurai Y
    Gan; 1975 Dec; 66(6):719-20. PubMed ID: 1225724
    [No Abstract]   [Full Text] [Related]  

  • 25. Influence of mitotic cycle inhibitors on the antileukemic activity of cytosine arabinoside (NSC-63878) in mice bearing leukemia L1210.
    Vadlamudi S; Goldin A
    Cancer Chemother Rep; 1971 Dec; 55(5):547-55. PubMed ID: 5159846
    [No Abstract]   [Full Text] [Related]  

  • 26. Electronic volume analysis of L1210 chemotherapy.
    Zucker RM; Helfman D
    Cancer Res; 1976 Dec; 36(12):4434-8. PubMed ID: 1000492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Response of lymphoid leukemia L1210 in mice to implantable sustained release cytosine arabinoside capsules.
    Fu JC; Khwaja T; Moyer DL; Cummings L; Varvan J; Elshire D
    J Surg Oncol; 1978; 10(1):1-7. PubMed ID: 628213
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy: some concepts and results.
    Skipper HE
    Cancer Chemother Rep 2; 1974 Mar; 4(1):137-45. PubMed ID: 4363649
    [No Abstract]   [Full Text] [Related]  

  • 29. Increased tolerance of leukemic mice to arabinosyl cytosine with schedule adjusted to circadian system.
    Haus E; Halberg F; Pauly JE; Cardoso S; Kühl JF; Sothern RB; Shiotsuka RN; Hwang DS
    Science; 1972 Jul; 177(4043):80-2. PubMed ID: 5041782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sparing action of uridine on the activity of arabinosylcytosine with normal and leukemic mice.
    Saslaw LD; Grindey GB; Kline I; Waravdekar VS
    Cancer Res; 1968 Jan; 28(1):11-20. PubMed ID: 5635365
    [No Abstract]   [Full Text] [Related]  

  • 31. Deveopment of resistance to combinations of six antimetabolites in mice with L1210 leukemia.
    Schmid FA; Hutchison DJ; Otter GM; Stock CC
    Cancer Treat Rep; 1976 Jan; 60(1):23-7. PubMed ID: 1000516
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Influence of route of administration on antileukemic activity of cytosine arabinoside (NSC-63878) in advanced leukemia L1210 in mice.
    Kline I; Tyrer DD; Gang M; Venditti JM; Goldin A
    Cancer Chemother Rep; 1968 Apr; 52(3):399-404. PubMed ID: 5670722
    [No Abstract]   [Full Text] [Related]  

  • 33. Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.
    Avery TL; Roberts D
    Eur J Cancer (1965); 1974 Jul; 10(7):425-9. PubMed ID: 4457345
    [No Abstract]   [Full Text] [Related]  

  • 34. A new anti-cancer principle isolated from Gymnosporia rothiana Laws, and its use in attaining cures in L1210 leukaemia in combination with "S" phase sensitive drugs.
    Alate AD; Khandalekar DD; Amonkar AJ; Adwankar MK; Sahasrabudhe MB
    Biomedicine; 1978 Oct; 28(5):270-3. PubMed ID: 743552
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Active immunotherapy in spontaneous leukemia of AkR mice.
    Mathé G; Halle-Pannenko O; Bourut C
    Exp Hematol; 1973; 1(2):110-4. PubMed ID: 4609352
    [No Abstract]   [Full Text] [Related]  

  • 36. [Modern aspects of using chronopharmacology in hematology. II. Biorhythms in drug effects].
    Berger J; Mikeska J
    Cas Lek Cesk; 1985 Sep; 124(38-39):1220-2. PubMed ID: 4053157
    [No Abstract]   [Full Text] [Related]  

  • 37. Role of cholesterol in enhancing the antitumor activity of cytosine arabinoside entrapped in liposomes.
    Mayhew E; Rustum YM; Szoka F; Papahadjopoulos D
    Cancer Treat Rep; 1979; 63(11-12):1923-8. PubMed ID: 526925
    [No Abstract]   [Full Text] [Related]  

  • 38. Reduction in the frequency of mutation to resistance to cytarabine in L1210 murine leukemic cells by treatment with quinacrine hydrochloride.
    Bach MK
    Cancer Res; 1969 Oct; 29(10):1881-5. PubMed ID: 5823955
    [No Abstract]   [Full Text] [Related]  

  • 39. Adriamycin and cyclophosphamide in combination chemotherapy of L1210 leukemia.
    Avery TL; Roberts D
    Cancer Res; 1977 Mar; 37(3):678-83. PubMed ID: 837368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combination chemotherapy of L1210 leukemia with platinum compounds and cyclophosphamide plus other selected antineoplastic agents.
    Glae GR; Atkins LM; Meischen SJ; Smith AB; Walker EM
    J Natl Cancer Inst; 1976 Dec; 57(6):1363-6. PubMed ID: 187805
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.